Digital Realty Trust, Inc. vs TransMedics Group Inc — how do they compare? Digital Realty Trust, Inc. trades at $191.45 (market cap $70.61B), while TransMedics Group Inc trades at $89.19 (market cap $3.10B). The key difference: Digital Realty Trust, Inc. is far larger — about 22.8× TransMedics Group Inc's market cap, and Digital Realty Trust, Inc. pays a 2.56% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| DLR | TMDX | |
|---|---|---|
Market Cap | $70.61B | $3.10B |
Sector | Real Estate | Technology |
52-Week High | $203.91 | $150.42 |
52-Week Low | $147.93 | $61.99 |
Enterprise Value | $89.32B | $3.49B |
Dividend Yield | 2.56% | — |
Trailing returns across standard periods
Latest headlines on both assets
Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.
Read more on DLR →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →